News
Congratulations to our portfolio company, Syntis Bio, on their $38M Series A round!
Our Boston-based portfolio company, Syntis Bio, recently announced their $38M Series A round to help target obesity and rare diseases. Syntis CEO and Founder, Rahul Dhanda was recently featured in Endpoints to discuss the raise.
Get in touch
Chicago | Boston | Atlanta | Houston
©2025 Portal Innovations, LLC
Sign up for our monthly newsletter
Stay up-to-date on the latest VC, biotech, and med tech news in Chicago and across the U.S. Sign up with your email address below to get our monthly newsletter delivered to your inbox!